TP53 and neoplasm: Moreover, our genomic analysis revealed a correlation between CTSL and mutations in P53, ATRX, and PTEN, and TP53 mutations were associated with poor survival in HNSCC patients and tumor resistance to radiation and chemotherapy clinically (22).